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Two clones of N1 gene derived from isolate A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007 (H5N1) exhibit single
mismatch of amino acid sequence at position 242 that is threonine and methionine for the clone #3 and #5,
respectively. In order to evaluate the effect of the amino acid substitution, these clones were inserted into two
different expression vectors that are pEGFP-C1 and pcDNA-3.3 TOPO® TA cloning. Subsequently, the respective
recombinant clones were transfected into eukaryotic cells, including CEF, RK13 and VERO using Lipofectamine
‘plus’ reagent. As a result, the clone #3 retaining atypical sequence showed lower expression level rather than the
clone #15 in both vectors and all type of cells. The 3D conformational modelling revealed that the mutation occurs
in the inner part of glycoprotein embedded within envelope or matrix. Therefore, the missense mutation seems has
no effect on the antigenic properties of neuraminidase but this substitution by any means causes lethal mutagenesis
in the individual gene expression by reducing level of protein transcript.
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INTRODUCTION
A surface glycoprotein of influenza virus,
neuraminidase contributes on the release of virus in the
final stage of replication (Colman et al. 1983; Murti &
Webster 1986; Colman 1998).  Neuraminidase also plays
important role on the process of protein transfer to the
apical plasma membrane in the progeny assembly (Kundu
& Nayak 1994; Kundu et al. 1996). This glycoprotein is
encoded by gene segment 6 with size in about 454 amino
acids in the tetramer configuration (Colman et al. 1983;
Varghese et al. 1983). As exterior property, the
neuraminidase gene has experienced rapid mutation
resulting in substantial genotypic variance (Zhou et al.
2009). However, genetic variation could also arise from
the lack of proofreading activity of RNA polymerase within
the viral replication (Steinhauer et al. 1992). Thus, the
mutations on the gene may have significant consequences
on the biological characteristics of the virus as well as on
the hemagglutinin gene (Castrucci et al. 1992; Brookes et
al. 2011; Ginting et al. 2012).
The previous gene cloning of neuraminidase of the
Indonesian H5N1 isolate into pGEM-T easy TA cloning
vector (Promega Corporation) generated two different
clones retaining full-length of the N1 gene, which are the
clone N1#3 and N1#15 (Hartawan et al. 2010). These clones
share almost identical sequence of nucleotide, except at
position 725 that is C or T for the #3 and #15, respectively.
In spite of this difference was suspected as error taq prone,
the effect of mutation could be crucial because it do not
only occur in the highly conserved area but it also codes
for dissimilar amino acid that is polar neutral threonine
and non-polar neutral methionine for the #3 and #15,
respectively (Greene 2004).
The objective of the study was to investigate in vitro
expression level of these neuraminidase clones using two
expression vectors, including pEGFP-C1 and pcDNA-3.3
TOPO® TA cloning vectors. The level of gene expression
in cell cultures was evaluated by assessing protein
production using either microscopy observation or
Western blotting analysis. In addition, the 3D
conformational study was also performed to pinpoint the
position of amino acid change within the protein
configuration in order to acknowledge significance of the
mutation.
MATERIALS  AND  METHODS
Source of N1 Gene. Full-length of N1 gene in the
plasmid pGEM-T easy TA cloning vector (Promega
Corporation) was derived from the Indonesian highly
pathogenic avian influenza H5N1 virus isolate A/Dk/
Tangerang/Bbalitvet-ACIAR-TE11/2007. The gene was
molecularly characterised as previously described
methodology (Hartawan et al. 2010). Therefore, two N1
clones (N1#3 and N1#15) retaining the full-length
neuraminidase gene were identified share almost similar
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sequence identity, except nucleotide at position 725 that
is C and T for #3 and #15 respectively. As a consequence,
this nucleotide difference leads to different encoded amino
acid at position 242 that is threonine and methionine for
clone #3 and #5, respectively.
Dissimilarity of the nucleotide was aligned with
sequences of other Indonesian H5N1 isolates in NCBI
Genbank database using clustal W (Bioedit 7) in order to
differentiate the atypical sequence from the majority
sequence. Numbering system of nucleotide and amino
acid was assembled based on isolate A/Gs/Gd/1/96. In
addition, the amino acid sequences of both clones were
compared thoroughly with A/Ck/West Java/1074/2003
(GU183467) to identify modification of neuraminidase gene
from the specific H5N1 virus isolated in the early period
of the disease outbreak in Indonesia.
Construction of N1 Gene Recombinant Expression
Plasmid Expression vectors. Two commercial expression
plasmids, pEGFP-C1 (Clontech) and pcDNA-3.3 TOPO®
TA cloning vector (INVITROGEN™), were utilised to
examine the expression level of these two N1 clones. The
vector pEGFP-C1 has been already utilised in gene
expression in cell culture model (Xu et al. 2006; Hartawan
et al. 2011). Meanwhile, the pcDNA-3.3 TOPO® TA cloning
vector according to manufacturer (INVITROGEN™) offers
more straightforward procedure with a potential for highly
level expression of gene target in mammalian cells (http://
www.invitrogen.com/etc/medialib/en/filelibrary/
b i o p r o d u c t i o n / p d f s . P a r . 7 1 2 9 9 . F i l e . d a t /
pcDNA3_3%20TOPO%20Cloning%20Manual.pdf).
Introduction of a Restriction Site into N1 Gene. Fusion
between full-length N1 gene and both vectors was initially
facilitated by a set of primers to introduce XhoI and ApaI
restriction site at upstream and downstream region of
neuraminidase gene, respectively (Table 1). Whereas the
forward primer was optimized with Kozak’s calculation
(Kozak 1990), the terminal part of the reverse primer was
incorporated with a six histidine peptide tag and stop
codon sequence.
The PCR was carried out in a 20 μl mixture containing
1X PCR buffer, 375 μM dNTP’s, 1.25 mM MgCl2, 0.5 μM of
each forward and reverse primer, 1 unit of Platinum® Taq
DNA polymerase (INVITROGEN™) and 1 μl of the
respective plasmid as template. The PCR was designed in
two cycling steps. Step I was 94 oC for 2 min for initial
denaturation, 10 cycles of 94 oC for 15 s (denaturation),
55 oC for 30 s (annealing) and 72 oC for 1.5 min (extension)
with final extension at 72 oC for 3 min. Meanwhile, Step II
was comprised of 25 cycles of 94 oC for 15 s (denaturation)
and 72 oC for 1.5 min (annealing & extension) with final
extension at 72 oC for 3 min. The PCR products were
visualized by agarose electrophoresis and purified using
QIAQuick gel extraction kit (QIAGEN®) as per
manufacturer’s instruction.
Cloning of N1 Gene into Expression Plasmid pEGFP-
C1. Ligation of the gene into the vector was initially
performed by double digestion of the plasmid and the
purified PCR products of the respective clone using ApaI
and XhoI (NEW ENGLAND Biolabs®Inc.) as per
manufacturer’s instruction. The digested fragments were
visualized by agarose electrophoresis and purified using
QIAQuick gel extraction kit (QIAGEN®) as per
manufacturer’s instruction. Subsequently, the digested N1
genes were ligated with the plasmid pEGFP-C1 (Clontech)
using the T4 DNA ligation enzyme and buffer (Promega
Corporation) as per manufacturer’s instruction.
Subsequently, the inserted plasmids were transformed
into electro-competent E. coli strain DH10B
(INVITROGEN™) by electroporation (1.8 KV, 4.10 mS).
The transformed cells were inoculated on LB agar plate in
presence of 30 μg/ml kanamycin. Screening test by PCR
was performed to bacterial colonies to identify
transformed cell with correct insertion. Several positive
clones were propagated in 10 ml of LB broth with addition
of 100 μg/ml kanamycin at 37 oC incubator for overnight
with gentle agitation. The respective plasmid was purified
from the culture using the QIAGEN® Plasmid Mini Kit
(QIAGEN®) as per manufacturer’s instruction. To select
representative of clone #3 and #15, several recombinant
plasmids were sequenced in Australian Genome Research
Facility (AGRF, Brisbane).
Cloning of N1 Genes into pcDNA-3.3 TOPO® TA
Cloning Vector. Gene insertion into pcDNA-3.3 TOPO®
TA cloning vector (INVITROGEN™) was performed
directly from the purified PCR products of the clone #3
and #15 as per manufacturer ’s instruction. The
recombinant plasmid was transformed into chemically
competent E. coli strain One Shot®TOP10
(INVITROGEN™) as per manufacturer’s instruction. The
transformed cells were inoculated onto LB agar plates in
presence of 100 μg/ml ampicillin. Screening test of several
colonies was performed by PCR to identify correct
insertion. The positive clones were propagated in 10 ml of
LB broth with addition of 100 μg/ml ampicillin at 37 oC
incubator for overnight with gentle agitation. The
respective plasmids were purified using the QIAGEN®
Plasmid Mini Kit (QIAGEN®) as per manufacturer’s
instruction. Subsequently, screening by sequencing was
undertaken in AGRF (Brisbane) to select suitable clone
for the expression trial.
Transfection of Recombinant Expression N1 Gene into
Cell Cultures. Three different eukaryotic cell cultures were
utilised in the expression trial, including chicken embryo
fibroblasts (CEF), rabbit kidney (RK13) and African green
Table 1. Oligonucleotide primers to introduce XhoI and ApaI restriction sites into the sequence termini of the N1 gene
    Primer                                                                             Primer sequence (5’-3’)
N1f-XhoI
N1r-6His-ApaI
GGGACTCGAGCCATGAATCCAAATCAGAAGATAATAACC
GCAGGGGCCCTTAatgatgatgatgatgatgCTTGTCAATGGTGAATGGCAACTC
Restriction enzyme sites are shown in bold type. The consensus Kozak’s sequence in the forward primers is underlined. The six histidine
peptide tag added to the reverse primers is shown in lowercase text.
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monkey kidney (VERO). Whereas the N1 genes in the
pEGFP-C1 system were expressed in all three cells, the
genes in the pcDNA-3.3 TOPO® TA cloning vector were
only expressed in the VERO cells. The respective
expression plasmid (1 μg) was transfected into the
respective cells in 6-wells/plate using the Lipofectamine
reagent (INVITROGEN™) enhanced with ‘Plus’ reagent
(INVITROGEN™) as per manufacturer’s instruction.
Detection of  N1 Gene Expression in Cell Cultures.
Level of the GFP fusion protein in the pEGFP-C1 vector
system was examined directly from transfected cell culture
in 6-wells/plate flask (NUNC) under fluorescence
microscope using a special filter for GFP. Moreover, sample
cells were collected using cell scraper for Western blotting
for detecting the GFP protein fusion. Meanwhile, the gene
expression in pcDNA-3.3 TOPO® TA cloning was only
analysed with Western blotting by detecting the six his
peptide tag fusion.
Study of 3D Conformation of Neuraminidase. The 3D
conformation modelling of neuraminidase was performed
using DS Modeller and  DS Standalone from Discovery
Studio for Modeling and Simulation (Accelrys Discovery
Studio versi 2.1) (Dharmayanti 2009). Beside to locate the
amino acid difference betwen the clone #3 and #15, the
3D modelling approach was also employed to pinpoint
the amino acid modification between the clones of A/Dk/
Tangerang/Bbalitvet-ACIAR-TE11/2007  and A/Ck/West
Java/1074/2003.
RESULTS
Neuraminidase Gene Characteristics of Indonesian
Isolates. With the exception of clone N1#3 of A/Dk/
Tangerang/Bbalitvet-ACIAR-TE11/2007, the multiple
sequence alignment of neuraminidase of two clones of
the isolate with other 214 Indonesian isolates confirms
that nucleotide at position 725 and amino acid at position
242 are constantly preserved as thymine and methionine,
respectively. This evidence supports the premise that the
C 725 in clone #3 maybe derived from PCR error. However,
this faulty still could be utilised to investigate a
consequence of amino acid substitution in this position
of N1 gene sequence. Moreover, the alignment with A/
Ck/West Java/1074/2003 revealed five amino acid
alterations, including T40K, S105N, G201E, E259K and
G382E (Figure 1). Comparing with isolate Gs/Gd/1/96, both
A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007 and A/Ck/
West Java/1074/2003 demonstrated 20 amino acids
deletion in the NA-stalk as for the characteristic of
genotype Z virus group that dominance in the most regions
in Asia (Li et al. 2004 Chen et al. 2006).
Figure 1. Multiple aligment of amino acid sequence of neuraminidase between A/Gs/Gd/1/96, A/Ck/West Java/1074/2003 and both
clones of A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007 (N1#3 & N1#15). The 20 amino acids deletion is displayed in the
white box. Five amino acid modification between  A/Ck/West Java/1074/2003 and A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/
2007 are highlighted by the grey bar with one asterisk, including in position T40K, S105N, G201E, E259K, and G382E.
Meanwhile, the amino acid difference between the clone #3 and #15 (T242M) was highlighted by the grey bar with two
asterisks.
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Fusion of N1 Genes into Expression Vectors. Cloning
of N1 gene into vector pEGFP-C1 was successfully carried
out from the designated clones (pGEM-TE/N1#3 & pGEM-
TE/N1#15) that identified as pEGFP-C1/N1#3 and pEGFP-
C1/N1#15 (Figure 2a,b). Correspondingly, the genetic
material of these two pGEM-T easy clones was also
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Figure 2. Screening for recombinant clones carrying full-length N1 genes of isolate A/DK/Tangerang/Bbalitvet-ACIAR-TE11/2007. (a)
PCR screening of the pEGFP-C1/N1#3; (b) PCR screening for the pEGFP-C1/N1#15; (c) PCR screening for pcDNA-3.3/
N1#3; (d) PCR screening for the pcDNA-3.3/N1#15.
                         GFP-control                                                     GFP-N1#3                                                      GFP-N1#15
CEF cells
                                 a                                                                         b                                                                     c
RK13 cells
                                 d                                                                         e                                                                     f
VERO cells
                                 g                                                                        h                                                                     i
Figure 3. Detection of the GFP fusion protein in cell cultures after 48 hours incubation using fluoroscopy microscope. (a) GFP in CEF;
(b) GFP-N1#3 in CEF; (c) GFP-N1#15 in CEF; (d) GFP in RK13; (e) GFP-N1#3 in RK13; (f) GFP-N1#15 in RK13; (g) GFP
in VERO; (h) GFP-N1#3 in VERO; (i) GFP-N1#15 in VERO.
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successfully inserted into plasmid pcDNA-3.3 TOPO® TA
cloning vector. These two derived clones of N1 gene were
identified as pcDNA3.3/N1#3 and pcDNA3.3/N1#15
(Figure 2c,d). Gene sequencing confirmed that all
recombinant clones were consistent to their original clones
In vitro Expression Level of N1 Clones. Gene
expression of the N1 gene products fused to GFP was
observed in all transfected cell lines. Observation using
fluorescence microscopy on GFP fusion protein confirmed
for maximum expression within 48 hours after transfection.
In addition, expression level of GFP fusion protein was
higher using the cell lines (RK13 & VERO) rather than in
the CEF primary cell culture (Figure 3). Interestingly, there
was different level of expression between these two
clones. Clone #15 demonstrated higher level of expression
than the clone #3 (Figure 3). Western blotting analysis of
these two N1 clones also confirmed similar outcome (Figure
4a,b,c). The level of GFP-N1 fusion protein from the clone
#15 was observed in higher amount in all three types of
cell culture rather than the clone #3. Furthermore, Western
blotting analysis of the native N1 gene expression in
pcDNA-3.3TOPO® TA cloning vector demonstrated a clear
difference between these two N1 clones (Figure 5). Native
N1 protein of the clone #15 was clearly produced in higher
amount compared to the other clones.
The 3D Modelling of Neuraminidase. The 3D
structural approach confirmed that all six points of amino
acid substitutions addressed on the study occur within
internal structure of neuraminidase buried within envelope
and matrix (Figure 6). Most of the mutations change
properties of encoded amino acid, including side-chain
polarity and charge (Table 2). Since the neuraminidase
motif of A/duck/Tangerang/Bbalitvet-ACIAR-TE11/2007
shows 20 amino acids deletion similar with other
Indonesian isolates (Dharmayanti et al. 2008; Dharmayanti
et al. 2011), two numbering systems of amino acid were
                                 a                                                                        b                                                                     c
Figure 4. Western blotting analysis of GFP-N1 fusion protein in cell culture after 48 hours incubation. (a) N1 gene expression in CEF;
(b) N1 gene expression in RK13; (c) N1 gene expression in VERO. Whereas grey arrow with one asterisk indicates presence
of GFP protein, grey arrow with two asterisks indicates GFP-N1 fusion protein.
Figure 5. Western blotting analysis of N1-his tag fusion protein in VERO cell culture after 24, 48, and 72 hours incubation. Grey arrow
indicates presence of N1-his tag fusion protein.
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employed to compromise the difference of neuraminidase
motif with isolate Gs/Gd/1/96, which are Gs/Gd/1/96
numbering system and Indonesian isolate (A/Ck/West
Java/1074/2003) numbering system (Figure 6 & Table 2).
DISCUSSION
As a typical virus with notable mutation, the genetic
features of avian influenza virus strain H5N1 appear to be
divergent over time. In spite of the most variant was
observed on hemagglutinin gene, genetic alteration has
also occurred on the other genes (Perdue 2008; Suarez
2008). The positive epistasis phenomena occurred
between pair gene regions in the hemagglutinin and
neuraminidase gene in order to achieve pathogen fitness
(Kryazhimskiy et al. 2011). The evidence of variation on
the neuraminidase gene resulting in six different groups
was previously documented (Zhou et al. 2009). However,
the modification of neuraminidase should not be limited
solely on this grouping because of the evidence of
antigenic drift. For example, several oseltamivir-resistant
influenza strains arise because of mutation on the
neuraminidase gene (Moscona 2005; Collins et al. 2008).
Despite the oseltamivir-resistant strains are inefficient in
replication but permissive mutation of the gene could
overcome the problem (Myers & Hensley 2011). Moreover,
a study by Hensley et al. (2011) revealed that escape
mutation of hemagglutinin against host antibody could
lead to mutation on neuraminidase gene resulting in
resistance against neuraminidase inhibitor.
In comparison with A/Ck/West Java/1074/2003 that
was isolated in the early period of H5N1 outbreak in
Indonesia, A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007
demonstrated five amino acid modifications of within
internal part of neuraminidase that are submerged in the
envelope and/or matrix by the 3D modelling approach.
These all modifications seem have no relevance with
external factors such as pressure from host or vaccine
immunity that may result in mutation since no alteration
on the surface structure of neuraminidase. Thus, these all
modifications are predicted to be genuinely originated from
internal factor as a result of lacking virus polymerase
activity (Steinhauer et al. 1992).
Figure 6. The 3D conformational modelling of neuraminidase protein structure of the two N1 clones of A/Dk/Tangerang/Bbalitvet-
ACIAR-TE11/2007 (the clone #3 & #15) in comparison with A/Ck/West Java/1074/2003. Whereas the amino acid difference
between the clone #3 and #15 is displayed in the black box, the five amino acid modification between A/Ck/West Java/1074/
2003 and A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007 are displayed in the red box. *Gs/Gd/1/96 numbering system.
**Indonesian isolate numbering system.
Tabel 2.  The amino acid modification of the two clones of A/duck/Tangerang/Bbalitvet-ACIAR-TE11/2007 (N1#3 & N1#15) with A
Ck/West Java/1074/2003
      Amino acid position                                                         Amino acid change (side-chain polarity, charge)
                                                                                                                 A/Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007Gs/Gd/1/96
numbering
system
Indonesian
isolate
numbering system
A/Ck/West Java/
1074/2003
40
105
201
242
259
382
40
85
181
222
239
362
Threonine (polar, neutral)
Serine (polar, neutral)
Glysine (non-polar, neutral)
Methionine (non-polar, neutral)
Glutaminic acid (polar, negative)
Glysine (non-polar, neutral)
Lysine (polar, positive)
Asparagine (polar, neutral)
Glutaminic acid (polar, negative)
Threonine (polar, neutral)
Lysine (polar, positive)
Glutaminic acid (polar, negative)
Lysine (polar, positive)
Asparagine (polar, neutral)
Glutaminic acid (polar, negative)
Methionine (non-polar, neutral)
Lysine (polar, positive)
Glutaminic acid (polar, negative)
Clone #3 Clone #15
174     HARTAWAN  ET AL.                                                                                                                                          HAYATI J Biosci
Multiple alignment of neuraminidase gene of 215
Indonesian isolates confirmed that gene modification
could occur randomly within segment but several regions
are rigidly preserved. In the case of two N1 clones of A/
Dk/Tangerang/Bbalitvet-ACIAR-TE11/2007, these clones
demonstrate amino acid modification from non-polar
methionine to polar threonine at position 242 that is
constantly preserved as methionine. As a consequence,
this mutation significantly reduces the expression level
of individual gene as in vitro in eukaryotic cells. This
mutation does not only change the side-chain polarity of
the encoded amino acid but it also occurs at the very
highly conserved area. However, location of the mutation
appears to be more influence on the reduction of
expression level rather than the attribute change of
encoded amino acid. This premise is supported by several
amino acid modifications with different polarity and charge
between the clone #15 (A/Dk/Tangerang/Bbalitvet-
ACIAR-TE11/2007) and A/Ck/West Java/1074/2003.
In the concept of quasispecies, mutations may not
only give rise to superior variants but it also could lead to
deficient progeny as lethal mutagenesis (Lauring & Andino
2010). However, the study by Bergmann and Muster (1995)
demonstrated that reduction of the neuraminidase specific
genomic RNA in infected cell of neuraminidase-mutant
have no correlation with amount of RNA particle in the
virus after virion packaging. Later, the authors mentioned
about the significance of mutation in neuraminidase gene
since the mutant become less virulent in the mouse model.
Moreover, 3D structural modelling confirms the point of
amino acid difference between these two clones occurs in
the embedded part of the neuraminidase glycoprotein. This
missense mutation seems has no effect on the antigenic
properties but it appears become disadvantage by reducing
level of protein transcript in replication. Furthermore,
mapping of this kind point of lethal mutation within avian
influenza genes will be beneficial in the development
antiviral therapeutic by RNA silencing using short hairpin
RNA (shRNA). The possibility of virus mutation as
respond to the shRNA treatment may less occurred within
the area of lethal mutation.
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